{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:34:34Z","timestamp":1788021274098,"version":"build-2784847793"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ajog.2017.11.565","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T20:22:45Z","timestamp":1512764565000},"page":"S829-S840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"S","title":["The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-5617","authenticated-orcid":false,"given":"Katie M.","family":"Groom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.11.565_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","article-title":"Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy","volume":"4","author":"Pijnenborg","year":"1983","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.11.565_bib2","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1067\/mob.2002.127305","article-title":"The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature","volume":"187","author":"Brosens","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib3","first-page":"177","article-title":"The role of the spiral arteries in the pathogenesis of preeclampsia","volume":"1","author":"Brosens","year":"1972","journal-title":"Obstet Gynecol Annu"},{"key":"10.1016\/j.ajog.2017.11.565_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0002-9440(10)61778-6","article-title":"In\u00a0vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies","volume":"159","author":"Hung","year":"2001","journal-title":"Am J Pathol"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2017.11.565_bib5","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.placenta.2004.01.003","article-title":"Trophoblast oxidative stress, antioxidants and pregnancy outcome\u2014a review","volume":"25","author":"Poston","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.11.565_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.565_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.565_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.11.565_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Labarrere","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","volume":"93","author":"Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1096\/fj.00-0376com","article-title":"Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction","volume":"15","author":"Barber","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2017.11.565_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0002-9378(91)90317-K","article-title":"Maternal plasma level of endothelin is increased in preeclampsia","volume":"165","author":"Nova","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/HYPERTENSIONAHA.108.115006","article-title":"Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia","volume":"52","author":"Sandrim","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.CIR.75.5.956","article-title":"Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension","volume":"75","author":"Fitzgerald","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2017.11.565_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajog.2017.11.565_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0006-291X(03)01504-3","article-title":"Heme oxygenase-1 induction may explain the antioxidant profile of aspirin","volume":"308","author":"Grosser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajog.2017.11.565_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.HYP.34.1.96","article-title":"Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension","volume":"34","author":"Wang","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.109.134825","article-title":"Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines","volume":"54","author":"Snoep","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ajh.2009.83","article-title":"Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension","volume":"22","author":"Hermida","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2017.11.565_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/07420521003624662","article-title":"Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects","volume":"27","author":"Ayala","year":"2010","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ajog.2017.11.565_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"issue":"3 Pt 2","key":"10.1016\/j.ajog.2017.11.565_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.30.3.589","article-title":"Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women","volume":"30","author":"Hermida","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib26","article-title":"Evidence-based guidelines for the management of suspected fetal growth restriction: comparison and convergence","author":"McCowan","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.565_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2017.11.565_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0038-1646526","article-title":"Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy","volume":"61","author":"Omri","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib30","first-page":"507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.ajog.2017.11.565_bib31","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2009.11.030","article-title":"Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy","volume":"125","author":"Oberkersch","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2017.11.565_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1160\/TH08-12-0832","article-title":"Anti-cancer properties of low-molecular-weight heparin: preclinical evidence","volume":"102","author":"Mousa","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib33","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ajog.2004.05.014","article-title":"Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in\u00a0vitro","volume":"191","author":"Bose","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in\u00a0vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/AOG.0b013e31821b5384","article-title":"Angiogenic response of placental villi to heparin","volume":"117","author":"Sobel","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.placenta.2014.12.008","article-title":"Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor","volume":"36","author":"Yinon","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.11.565_bib38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.placenta.2006.04.001","article-title":"Low-molecular weight heparin induces in\u00a0vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors","volume":"28","author":"Di Simone","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2017.11.565_bib39","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/humrep\/dem201","article-title":"Effect of heparin and fractionated heparin on trophoblast invasion","volume":"22","author":"Ganapathy","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.11.565_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.AOG.0000128902.84876.d4","article-title":"Effects of low-molecular-weight and unfractionated heparin on trophoblast function","volume":"104","author":"Quenby","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib41","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/j.1538-7836.2011.04526.x","article-title":"Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling","volume":"9","author":"Drewlo","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib42","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ultrasmedbio.2006.05.030","article-title":"Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension","volume":"32","author":"Torricelli","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.ajog.2017.11.565_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1471-0528.13421","article-title":"Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results","volume":"123","author":"Abheiden","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.565_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.11.565_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.13209","article-title":"LMWH to prevent placenta-mediated pregnancy complications: an update","volume":"168","author":"Duffett","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2017.11.565_bib48","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2017.11.565_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib51","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.565_bib52","first-page":"296","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial","volume":"216","author":"Groom","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","article-title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","volume":"123","author":"Rodger","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2017.11.565_bib54","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.11.565_bib55","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1160\/TH16-02-0169","article-title":"LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis","volume":"116","author":"Mastrolia","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2017.11.565_bib56","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.11.565_bib57","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature06951","article-title":"Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia","volume":"453","author":"Kanasaki","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2017.11.565_bib58","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.186270","article-title":"Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model","volume":"59","author":"Stanley","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib59","doi-asserted-by":"crossref","first-page":"e77748","DOI":"10.1371\/journal.pone.0077748","article-title":"Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype","volume":"8","author":"Dilworth","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.11.565_bib60","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.116.07662","article-title":"Maternal administration of sildenafil citrate alters fetal and placental growth and fetal-placental vascular resistance in the growth-restricted ovine fetus","volume":"68","author":"Oyston","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajog.2008.08.029","article-title":"The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus","volume":"200","author":"Miller","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0032-1304823","article-title":"Effects of sildenafil in nomega-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model","volume":"29","author":"Nassar","year":"2012","journal-title":"Am J Perinatol"},{"issue":"5 Pt 2","key":"10.1016\/j.ajog.2017.11.565_bib63","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/01.AOG.0000125148.82698.65","article-title":"Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine","volume":"103","author":"Lacassie","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib64","first-page":"87","article-title":"Eisenmenger's syndrome in a 27 week pregnancy\u2014management with bosentan and sildenafil","volume":"98","author":"Molelekwa","year":"2005","journal-title":"Ir Med J"},{"key":"10.1016\/j.ajog.2017.11.565_bib65","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.4076\/1752-1947-3-7255","article-title":"Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report","volume":"3","author":"Streit","year":"2009","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.ajog.2017.11.565_bib66","first-page":"414","article-title":"[Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension]","volume":"49","author":"Sun","year":"2014","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.ajog.2017.11.565_bib67","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.2174\/1381612811209023034","article-title":"The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature","volume":"18","author":"Iacovidou","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajog.2017.11.565_bib68","first-page":"CD005494","article-title":"Sildenafil for pulmonary hypertension in neonates","author":"Shah","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.11.565_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A\u00a0randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2017.11.565_bib70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib71","first-page":"632","article-title":"Sildenafil citrate and uteroplacental perfusion in fetal growth restriction","volume":"17","author":"Dastjerdi","year":"2012","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.ajog.2017.11.565_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/uog.11142","article-title":"Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy","volume":"40","author":"Lin","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib73","first-page":"168","article-title":"Sildenafil citrate in fetal growth restriction","volume":"15","author":"Panda","year":"2014","journal-title":"J\u00a0Reprod Infertil"},{"key":"10.1016\/j.ajog.2017.11.565_bib74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-0528.2010.02879.x","article-title":"Sildenafil citrate therapy for severe early-onset intrauterine growth restriction","volume":"118","author":"von Dadelszen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.565_bib75","unstructured":"Datasheet M. Data sheet silvasta 2016. Available at: http:\/\/www.medsafe.govt.nz\/profs\/Datasheet\/s\/silvastatab.pdf. Accessed November 29, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib76","unstructured":"Alfirevic Z, Baker P, Papageorghiou A, Johnstone E, Kenny L. STRIDER UK: a randomized controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction.\u00a02016. Available at: https:\/\/zenodo.org\/record\/56153#.Wh7bj1WnFhE. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib77","unstructured":"Groom KM, Baker P, McCowan LM, Stone PR, Lee AC. STRIDER (NZAus): a randomised controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction (New Zealand and Australia),\u00a02016. Available at: https:\/\/zenodo.org\/record\/56150#.Wh7cuVWnFhE. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib78","unstructured":"Ganzevoort W, Bloemenkamp KW, Von Dadelszen P, et\u00a0al. The Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction),\u00a02016. Available at: https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-3-23. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib79","unstructured":"Von Dadelszen P, Lim KI, Magee LA, Lalji S. STRIDER Canada: a randomized controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction,\u00a02016. Available at: https:\/\/zenodo.org\/record\/56152#.Wh7cgFWnFhE. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib80","unstructured":"Kenny L. The (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction (STRIDER) Ireland Protocol version 5.0.\u00a02017. Available at: https:\/\/zenodo.org\/record\/496143#.Wh7c0lWnFhE. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2046-4053-3-23","article-title":"STRIDER (Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction)\u2014a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis","volume":"3","author":"Ganzevoort","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajog.2017.11.565_bib82","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/hum.2015.095","article-title":"Recent advancements in cardiovascular gene therapy and vascular biology","volume":"26","author":"Laakkonen","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajog.2017.11.565_bib83","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/gt.2008.102","article-title":"Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep","volume":"15","author":"David","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.ajog.2017.11.565_bib84","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/gt.2011.158","article-title":"Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep","volume":"19","author":"Mehta","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.ajog.2017.11.565_bib85","doi-asserted-by":"crossref","first-page":"e100021","DOI":"10.1371\/journal.pone.0100021","article-title":"Local over-expression of VEGF-DDeltaNDeltaC in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis","volume":"9","author":"Mehta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.11.565_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1095\/biolreprod.115.133744","article-title":"Peri- and postnatal effects of prenatal adenoviral VEGF gene therapy in growth-restricted sheep","volume":"94","author":"Carr","year":"2016","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2017.11.565_bib87","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2013.214","article-title":"Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies","volume":"25","author":"Carr","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajog.2017.11.565_bib88","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/1933719116630411","article-title":"Gene targeting to the uteroplacental circulation of pregnant guinea pigs","volume":"23","author":"Mehta","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2017.11.565_bib89","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","article-title":"Maternal therapy with Ad.VEGF-A165 increases fetal weight at term in a guinea-pig model of fetal growth restriction","volume":"27","author":"Swanson","year":"2016","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajog.2017.11.565_bib90","unstructured":"Royal College of Obstetrics and Gynaecology. The role of emergency and elective interventional radiology in postpartum haemorrhage.\u00a02007. Good Practice No. 6. Available at: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/goodpractice6roleemergency2007.pdf. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/humc.2015.2518","article-title":"Introduction: gene therapy and gene transfer projects of the 7th Framework Programme for Research and Technological Development of the European Union (second part)","volume":"26","author":"Gancberg","year":"2015","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.ajog.2017.11.565_bib92","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12884-017-1226-7","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction","volume":"17","author":"Spencer","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2017.11.565_bib94","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2217\/nnm-2016-0234","article-title":"Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications?","volume":"11","author":"Harris","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ajog.2017.11.565_bib95","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nature00819","article-title":"Placental-specific IGF-II is a major modulator of placental and fetal growth","volume":"417","author":"Constancia","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2017.11.565_bib96","doi-asserted-by":"crossref","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajog.2017.11.565_bib97","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1095\/biolreprod.104.033985","article-title":"Uterine artery remodeling and reproductive performance are impaired in endothelial nitric oxide synthase-deficient mice","volume":"72","author":"van der Heijden","year":"2005","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2017.11.565_bib98","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/thno.19678","article-title":"Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired uteroplacental perfusion in pregnancy","volume":"7","author":"Cureton","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ajog.2017.11.565_bib99","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1038\/s41598-017-06300-1","article-title":"Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development","volume":"7","author":"Phillips","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2017.11.565_bib100","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.7150\/thno.18845","article-title":"Placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of intrinsic placental growth signaling","volume":"7","author":"Beards","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ajog.2017.11.565_bib101","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib103","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2017.11.565_bib104","unstructured":"Statins to ameliorate early onset pre-eclampsia ISRCTN23410175. Available at: http:\/\/www.isrctn.com\/ISRCTN23410175. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib105","unstructured":"Pravastatin for prevention of preeclampsia NCT01717586."},{"key":"10.1016\/j.ajog.2017.11.565_bib106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000010278","article-title":"Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia","volume":"50","author":"Martinez-Abundis","year":"2000","journal-title":"Gynecol Obstet Invest"},{"issue":"4 Pt 1","key":"10.1016\/j.ajog.2017.11.565_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0895-7061(98)00249-0","article-title":"The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension","volume":"12","author":"Thaler","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2017.11.565_bib108","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-2115(97)02743-7","article-title":"The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in pre-eclampsia","volume":"73","author":"Makino","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2017.11.565_bib109","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/ars.2009.2945","article-title":"The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia","volume":"12","author":"Wang","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ajog.2017.11.565_bib110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.2013030291","article-title":"Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor","volume":"25","author":"Holwerda","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2017.11.565_bib111","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2017.11.565_bib112","doi-asserted-by":"crossref","first-page":"e008211","DOI":"10.1136\/bmjopen-2015-008211","article-title":"Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol","volume":"5","author":"Cluver","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2017.11.565_bib113","unstructured":"Preterm Labour and Birth. National Institute for Health and Care Excellence, Clinical Guidelines. London (United Kingdom): National Institute for Health and Care Excellence;\u00a02015."},{"key":"10.1016\/j.ajog.2017.11.565_bib114","doi-asserted-by":"crossref","unstructured":"American College of Obstetrics and Gynecologists' Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Antenatal Corticosteroid Therapy for Fetal Maturation. Committee Opinion No. 677: Obstet Gynecol 2016;128:e187\u2013e194.","DOI":"10.1097\/AOG.0000000000001715"},{"key":"10.1016\/j.ajog.2017.11.565_bib115","series-title":"Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: clinical practice guidelines","year":"2015"},{"key":"10.1016\/j.ajog.2017.11.565_bib116","series-title":"Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines","year":"2010"},{"key":"10.1016\/j.ajog.2017.11.565_bib117","article-title":"Antenatal steroids, magnesium sulfate, and mode of delivery in fetal growth restriction","author":"Shah","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib118","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/ije\/dys116","article-title":"The placental origins of sudden cardiac death","volume":"41","author":"Barker","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2017.11.565_bib119","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajog.2008.06.056","article-title":"Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses","volume":"199","author":"Crispi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/apa.12811","article-title":"Very preterm birth and foetal growth restriction are associated with specific cognitive deficits in children attending mainstream school","volume":"104","author":"Kallankari","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ajog.2017.11.565_bib121","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"Two year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"issue":"6 Pt 1","key":"10.1016\/j.ajog.2017.11.565_bib122","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1542\/peds.98.6.1167","article-title":"Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison by birth weight and gestational age","volume":"98","author":"McCarton","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.11.565_bib123","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000085993","article-title":"Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion","volume":"27","author":"Miller","year":"2005","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.ajog.2017.11.565_bib124","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1203\/01.pdr.0000252546.20451.1a","article-title":"Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion","volume":"61","author":"Welin","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2017.11.565_bib125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000471797","article-title":"Effects of antenatal melatonin treatment on the cerebral vasculature in an ovine model of fetal growth restriction","volume":"39","author":"Castillo-Melendez","year":"2017","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.ajog.2017.11.565_bib126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jpi.12121","article-title":"Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction","volume":"56","author":"Miller","year":"2014","journal-title":"J\u00a0Pineal Res"},{"key":"10.1016\/j.ajog.2017.11.565_bib127","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1113\/jphysiol.2014.270934","article-title":"Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs","volume":"592","author":"Tare","year":"2014","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ajog.2017.11.565_bib128","first-page":"CD010527","article-title":"Melatonin for women in pregnancy for neuroprotection of the fetus","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.11.565_bib129","unstructured":"Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease (PREMELIP). 2015. Available at: ClinicalTrials.gov. Accessed August 31, 2017."},{"key":"10.1016\/j.ajog.2017.11.565_bib130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/pr.2012.174","article-title":"Creatine pretreatment prevents birth asphyxia-induced injury of the newborn spiny mouse kidney","volume":"73","author":"Ellery","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2017.11.565_bib131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajog.2007.10.790","article-title":"Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)?","volume":"198","author":"Ireland","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib132","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/pr.2016.153","article-title":"Maternal creatine supplementation during pregnancy prevents acute and long-term deficits in skeletal muscle after birth asphyxia: a study of structure and function of hind limb muscle in the spiny mouse","volume":"80","author":"LaRosa","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2017.11.565_bib133","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/1471-0528.14237","article-title":"Maternal creatine in pregnancy: a retrospective cohort study","volume":"123","author":"Dickinson","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.565_bib134","first-page":"CD010846","article-title":"Creatine for women in pregnancy for neuroprotection of the fetus","author":"Dickinson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.11.565_bib135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajog.2003.12.033","article-title":"N-acetylcysteine restores nitric oxide-mediated effects in the fetoplacental circulation of preeclamptic patients","volume":"191","author":"Bisseling","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3 Pt 2","key":"10.1016\/j.ajog.2017.11.565_bib136","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ajog.2005.05.083","article-title":"The use of N-acetylcysteine for the prevention of hypertension in the reduced uterine perfusion pressure model for preeclampsia in Sprague-Dawley rats","volume":"193","author":"Chang","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.565_bib137","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/1933719112440052","article-title":"Protective effect of N-acetylcysteine on liver damage during chronic intrauterine hypoxia in fetal guinea pig","volume":"19","author":"Hashimoto","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2017.11.565_bib138","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2005.09.007","article-title":"Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia","volume":"127","author":"Roes","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781732330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781732330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:20:30Z","timestamp":1757589630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293781732330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S000293781732330X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.11.565","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.11.565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}